life science investing Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock
Psychedelics Investing Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
Psychedelics Investing Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
Psychedelics Investing Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
Psychedelics Investing Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder
biotech investing SVN-SDN-14 PTSD Programme - Positive pre-clinical results with three high-performing candidates advancing to in vivo studies
Psychedelics Investing Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA
Psychedelics Investing Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights
CHARBONE Hydrogen Successfully Completes the Dismantling of Hydrogen Equipment in Quebec and Announces the Arrival of the Main Components in Sorel-Tracy
CHARBONE Hydrogene complete avec succes le demantelement des equipements d'hydrogene a Quebec et annonce l'arrivee des principales composantes a Sorel-Tracy
